American Journal of Managed Care

The American Journal of Managed Care is a monthly medical journal that undergoes peer review and is released by Managed Care & Healthcare Communications, LLC. In 2009, it achieved an impact factor of 2.74.

International, National, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#158986

United States

#47971

Health/Health Conditions and Concerns

#99

Traffic sources

Monthly visitors

Articles

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

1 day ago | ajmc.com | Pearl Steinzor

New research to be presented at this year’s European Congress on Obesity (ECO), taking place May 11-14 in Malaga, Spain, reveals that a new diagnosis of type 2 diabetes (T2D) is associated with an increased risk of developing certain obesity-related cancers—most notably liver, pancreatic, and bowel cancer—while showing no significant link to others such as endometrial or postmenopausal breast cancer.
Vitamin D’s Role in Colorectal Cancer Prevention, Immune Health

1 day ago | ajmc.com | Pearl Steinzor

Once known mainly for its role in bone health, vitamin D is now recognized as a powerful immune system modulator with the potential to prevent colorectal cancer (CRC), according to a study published in Nutrients.1 Acting through receptors on immune cells, vitamin D influences key processes like inflammation, T-cell activation, and tumor suppression.
Cost-Effectiveness Analysis: CKD Screening, SGLT2 Inhibitors Can Reduce Kidney Failure Risk, Racial Disparities

5 days ago | ajmc.com | Giuliana Grossi

Initiating chronic kidney disease (CKD) screening at age 55 yielded substantial reductions in kidney failure incidence and improvements in life expectancy across all racial and ethnic groups in the US in a recent cost-effectiveness analysis.1Researchers evaluated the potential impact of population-wide screening for CKD combined with sodium-glucose cotransporter 2 (SGLT2) inhibitors across different racial and ethnic groups in the US.
Consensus Guidelines Aim to Optimize DMD Gene Therapy Delivery

5 days ago | ajmc.com | Rose McNulty

Multidisciplinary coordination is of the utmost importance to ensure appropriate gene therapy administration, and consensus recommendations presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference aimed to provide practical guidelines to supplement existing frameworks for gene therapy treatment in Duchenne muscular dystrophy (DMD).1 Gene therapies have changed the treatment landscape for inherited neurological conditions in recent years, with FDA approvals...
At-Home DMD Video Assessment Found Valid, Reliable

6 days ago | ajmc.com | Rose McNulty

A home-based video assessment tool, the Duchenne Video Assessment (DVA) 2.0, is a reliable, valid measure of ease of movement for patients with Duchenne muscular dystrophy (DMD), according to a poster presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference.1 The assessment, which utilizes a secure mobile app, may allow for the evaluation of typical performance in the home setting instead of best performance in the clinical setting, according to the study...
Navigating Value, Efficacy in Modern CLL Treatment: Pierluigi Porcu, MD

6 days ago | ajmc.com | Kyle Munz |Pierluigi Porcu

As treatment advances continue to reshape chronic lymphocytic leukemia (CLL) care, clinicians face the growing challenge of aligning clinical efficacy with long-term cost sustainability, explained Pierluigi Porcu, MD, director, Division of Hematologic Malignancies, Jefferson Health. To strike this balance, he argued, will take a more holistic understanding of the patient factors and available resources that could impact their treatment.
Pausing BTK Inhibitors Does Not Strengthen COVID Vaccination in CLL

6 days ago | ajmc.com | Jared Kaltwasser

Patients with chronic lymphocytic leukemia (CLL) who are taking Bruton tyrosine kinase (BTK) inhibitors do not need to pause their medications when getting vaccinated against coronavirus disease 2019 (COVID-19), a new report has found.1Previous research had suggested that taking a 3-week pause from BTK inhibitors would improve SARS-CoV-2 antibody responses to vaccination, but the new report indicates that such a pause provides no significant benefit.
Genetic Tagging Offers Promise in Identifying Latent HIV Cells: Benjamin K. Chen, MD, PhD

6 days ago | ajmc.com | Julia Bonavitacola |Benjamin Chen

Benjamin K. Chen, MD, PhD, professor in the Division of Infectious Diseases, Department of Medicine in the Icahn School of Medicine at Mount Sinai, spoke about the results of his recently published study, which found that researchers could genetically tag immune cells with latent HIV. Chen was the senior author on the study published in Nature Communications. This transcript was lightly edited; captions were auto-generated.
AJMC® in the Press, April 18, 2025

6 days ago | ajmc.com | Julia Bonavitacola

A newsletter from the National Institute for Health Care Management Foundation referenced a study published in the March 2025 issue of The American Journal of Managed Care® (AJMC®). The study, “Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization,” found significant demographic disparities when it came to failed video visit occurrence, specifically in older adults and African American/Black patients.
Elinzanetant Effective for Menopause Symptoms Across BMI, Smoking Status

6 days ago | ajmc.com | Rose McNulty

Elinzanetant significantly reduced vasomotor symptoms (VMS), also known as hot flashes, associated with menopause overall and across a range of body mass index (BMI) and smoking history subgroups, according to pooled data from the phase 3 OASIS-1 (NCT05042362) and OASIS-2 (NCT05099159) trials.1,2 The findings were presented at the 2025 Academy of Managed Care Pharmacy Annual Meeting.